Contact this trialFirst, we need to learn more about you.
Corticosteroid
Ixazomib + Dexamethasone for Smoldering Multiple Myeloma
Recruiting1 awardPhase 1
Basking Ridge, New Jersey
This trial is testing the combination of two drugs, ixazomib and dexamethasone, in patients with early-stage multiple myeloma. The goal is to see if these drugs can prevent or delay the disease from getting worse. Ixazomib works by stopping cancer cells from breaking down proteins, and dexamethasone helps reduce inflammation and kill cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service